zatvoriť galériu
KK38 Haywards Heath - Na snímke fľaštička s vakcínou proti koronavírusu, ktorú vyvinuli vedci z Oxfordskej univerzity v spolupráci s farmaceutickou spoločnosťou AstraZeneca 2. januára 2021 v britskom meste Haywards Heath. FOTO TASR/AP
A vial of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca is checked as they arrive at the Princess Royal Hospital in Haywards Heath, England, Saturday Jan. 2, 2021. The UK has 530,000 doses available for rollout from Monday
KK38 Haywards Heath - Na snímke fľaštička s vakcínou proti koronavírusu, ktorú vyvinuli vedci z Oxfordskej univerzity v spolupráci s farmaceutickou spoločnosťou AstraZeneca 2. januára 2021 v britskom meste Haywards Heath. FOTO TASR/AP
A vial of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca is checked as they arrive at the Princess Royal Hospital in Haywards Heath, England, Saturday Jan. 2, 2021. The UK has 530,000 doses available for rollout from Monday